1Division of Infectious Diseases, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 2Center for Human Immunobiology, Department of Medicine, Feinberg ...
1UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. 2Systems Biology Ireland, UCD School of Medicine, University College Dublin, ...
2Department of Surgery, The University of Michigan Medical School, Ann Arbor, Michigan. 3Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan. 4Department of Cell and Developmental Biology ...
Washington University School of Medicine in St. Louis, Saint Louis, MO.
Revolution Medicines, Redwood City, CA.
Cellentia Inc., Foster City, CA. Search for other works by this author on: ...
AbstractSignificance:. Brimstalt Therapeutics is developing a small molecule drug for treatment of cancer patients with tumors that express the tumor associated enzyme (TAE), SULT1A1. The lead ...
Suzhou Genhouse Pharmaceutical Co., Ltd., Suzhou, China.
Abstract. TNG462 is a clinical-stage, MTA-cooperative PRMT5 inhibitor currently being evaluated in an ongoing phase I/II clinical trial for solid tumors with MTAP loss. Approximately 10-15% of all ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio (avelumab), a ...
At today’s Senate Health, Education, Labor, and Pensions Committee hearing, nominee for Secretary of the Department of Health and Human Services Robert F. Kennedy (RFK) Jr. refused to renounce his ...
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. 2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback